Profile photo Jim van Os

Jim van Os

Full Professor

Strategic program(s):

Biography

I have a background in Epidemiology (London School of Hygiene and Tropical Medicine) and Psychiatry (Institute of Psychiatry, King’s College London). My research has focused on elucidating the nature of mental variation in relation to context, and identifying the interactions between environment and genetic liability driving this variation. Over the course of my career, I have developed a passion for making psychiatry more relevant for its users in terms of diagnostic practice, the use of scientific findings to create clinical impact, health service organization, teaching and co-creation with users. I think there is an urgent need to balance the discourse and the scientific focus of the psychiatric profession on the one hand, and the needs and wishes of patients and their relatives on the other. In my work as Neuroscience Division leader at MUMC and now UMCU, I have attempted to forge collaboration between the clinical neurosciences in order to create patient value, for example in the area of neuromodulation. After several decades of directing activities in health care and research, I think effective leadership is about facilitating others, creating a community and fostering the network – in the shared belief that our work serves to inspire students and impact the lives of patients.

Education

Basic Teaching Qualification, BROK certified

Ten most important scientific publications

  • Van Os, J., Hanssen, M., Bijl, R.V. & Vollebergh, W. (2001) Prevalence of psychotic disorder and community level of psychotic symptoms: an urban-rural comparison. Archives of General Psychiatry, 58, 663-668.

  • Van Os, J., Hanssen, M., Bak, M., et al (2003) Do urbanicity and familial liability coparticipate in causing psychosis? American Journal of Psychiatry, 160, 477-482.
  • Van Os, J., Altamura, A.C., Bobes, J. et al (2004) Evaluation of the Two-Way Communication Checklist as a clinical intervention. Results of a multinational, randomised controlled trial. British Journal of Psychiatry, 184, 79-83.
  • van Os, J. & Kapur, S. (2009) Schizophrenia. Lancet, 374, 635-645.
  • van Os, J., Kenis, G. & Rutten, B.P. (2010) The environment and schizophrenia. Nature, 468, 203-212.
  • van Os, J. & Reininghaus, U. (2016) Psychosis as a transdiagnostic and extended phenotype in the general population. World Psychiatry, 15, 118-124.
  • Van Os J, Marsman A, Van Dam D, Simons CJ, GROUP Investigators (2017). Evidence That the Impact of Childhood Trauma on IQ Is Substantial in Controls, Moderate in Siblings, and Absent in Patients With Psychotic Disorder. Schizophrenia Bulletin, 43(2), 316-324.
  • Van Os J, Van Der Steen Y, Islam MA, Guloksuz S, Rutten BP, Simons CJ, GROUP Investigators (2017). Evidence that polygenic risk for psychotic disorder is expressed in the domain of neurodevelopment, emotion regulation and attribution of salience. Psychological Medicine, 47(14), 2421-2437.
  • Van Os, J. & Güloksuz, S. (2017). A critique of the popular “ultra-high risk” and “transition” paradigm in psychiatry. World Psychiatry,16, 200-206
  • Van Os, J., Verhagen, S., Marsman, et al. (2017) The Experience Sampling Method as an mHealth Tool to Support Self-monitoring, Self-Insight and Personalised Health Care in Clinical Practice. Depression and Anxiety, 34(6), 481-493.

Strategic program(s):

Contact

Research groups

Innovation in psychiatry

Research aim

Innovation in Psychiatry embraces patient involvement, use different data sources and tools & methods for personalized prediction and treatment. With a holistic approach, we aim to improve the well-being of individuals with mental health problems.

Go to group

Recent publications

Genetic susceptibility of cardiometabolic outcomes in schizophrenia spectrum disorders Chenxu Zhao, Bochao Lin, Elnaz Naderi, Sara Moazzen, Tesfa Dejenie Habtewold, Richard Bruggeman, Therese van Amelsvoort, Wiepke Cahn, Lieuwe de Haan, Marieke van der Pluijm, Claudia J.P. Simons, Jim van Os, Wim Veling, Behrooz Z. Alizadeh
Schizophrenia Research, 2026, vol. 292, p.103-115
Do we understand the real-world consequences of a future DSM? Lars Veldmeijer, Jim van Os
PLOS Mental Health, 2026, vol. 3
Levenslang antipsychotica? Een kwalitatieve analyse van vragen over afbouwen Stijn Crutzen, Jim van Os, Stynke Castelein
Tijdschrift voor Psychiatrie, 2026, vol. 68, p.64-69
Living With Bipolar Disorder and Medication PRN-A Case-Report Annemiek Dols, John Brennikmeijer, Jim van Os
Bipolar Disorders, 2026, vol. 28
Correction Franciska de Beer, Sanne Koops, Robert A. Schoevers, Wim Veling, Nico van Beveren, Lieuwe de Haan, Nynke Boonstra, Martijn Kikkert, Marieke Begemann, Inge van der Heijden, Joelle Hoornaar, Ellen Graveland, Jan Jaap Hage, Ruben Curfs, Albert Batalla Cases, Sybren Wiersma, Selene Veerman, Natalie Veen, Anton B.P. Staring, Gerdina Hendrika Maria Pijnenborg, Jörg Kurkamp, Henderikus Knegtering, Martijn de Jonge, Koen Grootens, Gunnar Faber, Truus van den Brink, Steven Berendsen, Maarten Bak, Therese van Amelsvoort, Toon Scheurink, Matej Djordjevic, Iris Hamers, Alban Voppel, Priscilla Oomen, Erna van’t Hag, Shiral Gangadin, Bodyl Brand, Joran Lokkerbol, P. Roberto Bakker, Sinan Gülöksüz, Bram Sieben Rosema, Machteld Marcelis, Sanne Schuite-Koops, Filip Smit, Jim van Os, Iris Sommer,
Scientific Reports, 2026, vol. 16
Euthanasia for mental suffering in young people Jim van Os, Damiaan Denys
World Psychiatry, 2026, vol. 25, p.143-144

Fellowships & Awards

Ramaer Medal Outstanding Research, Dutch Psychiatric Association, 1997

Association of European Psychiatrists research price 2003 (20.000 euro)

Member, KNAW (2011).

Fellow, King’s College London (2016).

Thompson-Reuter WoS list of ‘most influential scientific minds’ and ‘highly cited researchers’

External positions

Voorzitter - Website psychosenet.nl in de lucht houden - Pilootproject ontwikkeling publieke ggz - Stichting PsychoseNet

Raad van Toezicht - None - Raad van Toezicht GGZ-VS Opleiding